Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 43

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 43
---
 where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

(oo) . With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of
the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an “” and, together, “”)
is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
“”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating
to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any
Issuer Covered Person.

(pp) .
The Company and its Subsidiaries have complied in all material respects with all statutes and regulations related to the research, manufacture
and sale of its products to the extent applicable to the Company’s and its Subsidiaries’ activities. Items manufactured or
under investigation by the Company and its Subsidiaries comply with all applicable manufacturing practices regulations and other requirements
established by government regulators in the jurisdictions in which the Company or its Subsidiaries manufacture their products and Applicable
Law. The Company is not and its Subsidiaries are not the subject of any investigation by any authority with respect to the development,
testing, manufacturing and distribution of their products, nor has any investigation, prosecution, or other enforcement action been threatened
by any regulatory agency. Neither the Company nor any of its Subsidiaries has received from any regulatory agency any letter or other
document asserting